FindTrial
Sign In

Correlation between Nottingham Prognostic Index and Receptor status in breast cancer patients undergoing surgery

Hormone Receptor Status and Its Correlation with Nottingham Prognostic Index in Surgically Treated Breast Cancer Patients - NOPROREST

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085136
Enrollment
90
Registered
2025-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C509- Malignant neoplasm of breast of unspecified site Health Condition 3: C509- Malignant neoplasm of breast of unspecified site

Interventions

Control Intervention1: NIL: NIL

Sponsors

AIIMS, BBSR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Carcinoma breast patients undergoing MRM 2. Carcinoma breast undergoing BCS+ALND

Exclusion criteria

Exclusion criteria: 1. Patients undergoing BCS+SLND

Design outcomes

Primary

MeasureTime frame
Correlation between Nottingham prognostic index and receptor status in breast cancer undergoing surgeryTimepoint: 4 weeks—

Secondary

MeasureTime frame
To evaluate the changes in hormonal receptor status after administration of NACTTimepoint: 8 weeks—

Countries

India

Contacts

Public ContactDr Varun S M

AIIMS, BBSR

varungowdasm8@gmail.com7337842616

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026